Cargando…
PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429201/ http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d |
_version_ | 1785090651390476288 |
---|---|
author | Tsushima, Takafumi Masuda, Shin-Ichi Yoda, Natsumi Kainuma, Sayaka Tanaka, Kazusuke Shimoji, Sonoko Kimura, Kenji Arai, Hironori Utsu, Yoshikazu Imadome, Ken-Ichi Aotsuka, Nobuyuki |
author_facet | Tsushima, Takafumi Masuda, Shin-Ichi Yoda, Natsumi Kainuma, Sayaka Tanaka, Kazusuke Shimoji, Sonoko Kimura, Kenji Arai, Hironori Utsu, Yoshikazu Imadome, Ken-Ichi Aotsuka, Nobuyuki |
author_sort | Tsushima, Takafumi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104292012023-08-17 PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED Tsushima, Takafumi Masuda, Shin-Ichi Yoda, Natsumi Kainuma, Sayaka Tanaka, Kazusuke Shimoji, Sonoko Kimura, Kenji Arai, Hironori Utsu, Yoshikazu Imadome, Ken-Ichi Aotsuka, Nobuyuki Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429201/ http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Tsushima, Takafumi Masuda, Shin-Ichi Yoda, Natsumi Kainuma, Sayaka Tanaka, Kazusuke Shimoji, Sonoko Kimura, Kenji Arai, Hironori Utsu, Yoshikazu Imadome, Ken-Ichi Aotsuka, Nobuyuki PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title | PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title_full | PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title_fullStr | PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title_full_unstemmed | PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title_short | PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED |
title_sort | pb2422: patients with high ebv viral load after allogeneic hematopoietic stem cell transplantation associate good prognosis when rapid immunosuppressants dose reduction can be achieved |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429201/ http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d |
work_keys_str_mv | AT tsushimatakafumi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT masudashinichi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT yodanatsumi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT kainumasayaka pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT tanakakazusuke pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT shimojisonoko pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT kimurakenji pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT araihironori pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT utsuyoshikazu pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT imadomekenichi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved AT aotsukanobuyuki pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved |